Loading...

Clinuvel Pharmaceuticals Limited

CLVLY•PNK
Healthcare
Biotechnology
$6.79
$0.17(2.49%)
U.S. Market opens in 0h 55m

Clinuvel Pharmaceuticals Limited (CLVLY) Stock Overview

Explore Clinuvel Pharmaceuticals Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap342.1M
P/E Ratio14.78
EPS (TTM)$0.46
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$5.53
3 Months$9.37
1 Year Target$5.05

CLVLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Clinuvel Pharmaceuticals Limited (CLVLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.78 and a market capitalization of 342.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.43%
5-Day Change
7.54%
1-Month Change
-0.79%
3-Month Change
-15.18%
6-Month Change
-8.91%
Year-to-Date (YTD) Change
-19.98%
1-Year Change
-5.75%
3-Year Change
-49.92%
5-Year Change
-70.90%
All-Time (Max) Change
0.53%

Contact Information

https://www.clinuvel.com
61 3 9660 4900
535 Bourke Street, Melbourne, VIC, 3000

Company Facts

100 Employees
IPO DateJan 30, 2008
CountryAU
Actively Trading

Frequently Asked Questions